Mariana Ruiz, autor en Biblioteca Digital Médico Científica

Recommendations for the recognition, diagnosis, and management of patients with Post Covid-19 Condition (“long covid”): A Delphi study.

Mariana Ruiz / 21/07/2021

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Autor: Fecha […]

Documento, Documento-otros

Symptoms, Pulmonary Function and Functional Capacity Four Months after COVID-19.

Mariana Ruiz / 21/07/2021

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Autor: Fecha

Documento, Documento-otros

Integrative respiratory follow-up of severe COVID-19 reveals common functional and lung imaging sequelae.

Mariana Ruiz / 31/05/2021

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Autor: Fecha

Documento, Documento-otros

6-month consequences of COVID-19 in patients discharged from hospital: a cohort study

Mariana Ruiz / 23/04/2021

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Autor: Fecha

Documento, Documento-Fibrosis Hepática

Moderate alcohol consumption is associated with advanced fibrosis in non-alcoholic fatty liver disease and shows a synergistic effect with type 2 diabetes mellitus

Mariana Ruiz / 21/04/2021

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo. Autor: Fecha

Documento, Documento-Heridas y Ulceras

Abordaje y Manejo de las Heridas. Fascículo 9

Mariana Ruiz / 29/03/2021

Autor: Fecha de Publicación: Editorial:

Documento, Documento-Heridas y Ulceras

Curación avanzada de heridas

Mariana Ruiz / 17/03/2021

Lorem fistrum por la gloria de mi madre esse jarl aliqua llevame al sircoo. De la pradera ullamco qué dise

Documento, Documento-Fibrosis Hepática

Pathogenesis of Idiosyncratic Drug-Induced Liver Injury and Clinical Perspectives

Mariana Ruiz / 17/03/2021

Lorem fistrum por la gloria de mi madre esse jarl aliqua llevame al sircoo. De la pradera ullamco qué dise

Documento, Documento-otros

Prediction of the Development of Pulmonary Fibrosis Using Serial Thin-Section CT and Clinical Features in Patients Discharged after Treatment for COVID-19 Pneumonia

Mariana Ruiz / 12/03/2021

Lorem fistrum por la gloria de mi madre esse jarl aliqua llevame al sircoo. De la pradera ullamco qué dise

Documento, Documento-Fibrosis Pulmonar

Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: design of a double-blind, randomised, placebocontrolled phase II trial

Mariana Ruiz / 10/03/2021

Autor: Fecha de Publicación: Editorial:

Documento, Documento-Fibrosis Hepática, Hepatología

Pirfenidone restricts Th2 differentiation in vitro and limits Th2 response in experimental liver fibrosis

Mariana Ruiz / 10/03/2021

Autor: Fecha de Publicación: Editorial:

Documento, Documento-Fibrosis Hepática, Hepatología

Pirfenidone effectively reverses experimental liver fibrosis

Mariana Ruiz / 10/03/2021

Autor: Fecha de Publicación: Editorial:

Biblioteca Digital Médico Científica 2.0

Nombre del autor:Mariana Ruiz

Recommendations for the recognition, diagnosis, and management of patients with Post Covid-19 Condition (“long covid”): A Delphi study.

Symptoms, Pulmonary Function and Functional Capacity Four Months after COVID-19.

Integrative respiratory follow-up of severe COVID-19 reveals common functional and lung imaging sequelae.

6-month consequences of COVID-19 in patients discharged from hospital: a cohort study

Moderate alcohol consumption is associated with advanced fibrosis in non-alcoholic fatty liver disease and shows a synergistic effect with type 2 diabetes mellitus

Abordaje y Manejo de las Heridas. Fascículo 9

Curación avanzada de heridas

Pathogenesis of Idiosyncratic Drug-Induced Liver Injury and Clinical Perspectives

Prediction of the Development of Pulmonary Fibrosis Using Serial Thin-Section CT and Clinical Features in Patients Discharged after Treatment for COVID-19 Pneumonia

Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: design of a double-blind, randomised, placebocontrolled phase II trial

Pirfenidone restricts Th2 differentiation in vitro and limits Th2 response in experimental liver fibrosis

Pirfenidone effectively reverses experimental liver fibrosis

Acceso para profesionales de la salud